These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
420 related articles for article (PubMed ID: 2418846)
21. The positive inotropic effect of pimobendan involves stereospecific increases in the calcium sensitivity of cardiac myofilaments. Solaro RJ; Fujino K; Sperelakis N J Cardiovasc Pharmacol; 1989; 14 Suppl 2():S7-12. PubMed ID: 2478795 [TBL] [Abstract][Full Text] [Related]
22. Investigation on SCH00013, a novel cardiotonic agent with Ca++ sensitizing action. 1st communication: phosphodiesterase III inhibitory effect and class III antiarrhythmic effect in guinea-pig heart. Hino M; Sugawara H; Yoshimura A; Ogura A; Yoshioka K; Sakato M; Endoh M Arzneimittelforschung; 1999 May; 49(5):398-406. PubMed ID: 10367101 [TBL] [Abstract][Full Text] [Related]
23. Mechanisms of the contractile effects of levosimendan in the mammalian heart. Bokník P; Neumann J; Kaspareit G; Schmitz W; Scholz H; Vahlensieck U; Zimmermann N J Pharmacol Exp Ther; 1997 Jan; 280(1):277-83. PubMed ID: 8996207 [TBL] [Abstract][Full Text] [Related]
24. Phosphodiesterase inhibition by naloxone augments the inotropic actions of beta-adrenergic stimulation. Park WK; Chang CH; Chae JE; Kim MH; Cho YL; Ahn DS Acta Anaesthesiol Scand; 2009 Sep; 53(8):1043-51. PubMed ID: 19572940 [TBL] [Abstract][Full Text] [Related]
25. Adenosine inhibition of catecholamine-induced increase in force of contraction in guinea-pig atrial and ventricular heart preparations. Evidence against a cyclic AMP- and cyclic GMP-dependent effect. Böhm M; Brückner R; Hackbarth I; Haubitz B; Linhart R; Meyer W; Schmidt B; Schmitz W; Scholz H J Pharmacol Exp Ther; 1984 Aug; 230(2):483-92. PubMed ID: 6086891 [TBL] [Abstract][Full Text] [Related]
26. Pharmacological analysis of the cardiac actions of xamoterol, a beta adrenoceptor antagonist with partial agonistic activity, in guinea pig heart: evidence for involvement of adenylate cyclase system in its cardiac stimulant actions. Hattori Y; Sakuma I; Nakao Y; Kanno M J Pharmacol Exp Ther; 1987 Sep; 242(3):1077-85. PubMed ID: 2888870 [TBL] [Abstract][Full Text] [Related]
28. Phosphodiesterase isozyme inhibition, activation of the cAMP system, and positive inotropy mediated by milrinone in isolated guinea pig cardiac muscle. Silver PJ; Harris AL; Canniff PC; Lepore RE; Bentley RG; Hamel LT; Evans DB J Cardiovasc Pharmacol; 1989 Apr; 13(4):530-40. PubMed ID: 2470989 [TBL] [Abstract][Full Text] [Related]
29. Synthesis and positive inotropic effects of 1-acyl-5,6-diethoxy-2-methylthiobenzimidazoles. Garaliené V; Labanauskas L; Brukstus A; Dauksas V Arzneimittelforschung; 1998 Dec; 48(12):1137-42. PubMed ID: 9893927 [TBL] [Abstract][Full Text] [Related]
30. Increase in myofibrillar Ca2+ sensitivity induced by UD-CG 212 Cl, an active metabolite of pimobendan, in canine ventricular myocardium. Takahashi R; Endoh M J Cardiovasc Pharmacol; 2001 Feb; 37(2):209-18. PubMed ID: 11210003 [TBL] [Abstract][Full Text] [Related]
31. Effect on contractility of skinned fibres from mammalian heart and smooth muscle by a new benzimidazole derivative, 4,5-dihydro-6-[2-(4-methoxyphenyl)-1H-benzimidazol-5-yl]-5-methy l-3(2H )- pyridazinone. Rüegg JC; Pfitzer G; Eubler D; Zeugner C Arzneimittelforschung; 1984; 34(12):1736-8. PubMed ID: 6543308 [TBL] [Abstract][Full Text] [Related]
32. In vitro pharmacology of R 80122, a novel phosphodiesterase inhibitor. Wilhelm D; Wilffert B; Janssens WJ; Leidig A; Meuter C; Ebbert M; Peters T J Cardiovasc Pharmacol; 1992; 20(5):705-14. PubMed ID: 1280731 [TBL] [Abstract][Full Text] [Related]
33. High selectivity for inhibition of phosphodiesterase III and positive inotropic effects of MCI-154 in guinea pig myocardium. Bethke T; Meyer W; Schmitz W; Scholz H; Wenzlaff H; Armah BI; Brückner R; Raap A J Cardiovasc Pharmacol; 1993 Jun; 21(6):847-55. PubMed ID: 7687707 [TBL] [Abstract][Full Text] [Related]
34. Phosphodiesterase inhibition by enoximone in preparations from nonfailing and failing human hearts. Bethke T; Eschenhagen T; Klimkiewicz A; Kohl C; von der Leyen H; Mehl H; Mende U; Meyer W; Neumann J; Rosswag S Arzneimittelforschung; 1992 Apr; 42(4):437-45. PubMed ID: 1386515 [TBL] [Abstract][Full Text] [Related]
35. Positive inotropic effect of levosimendan is correlated to its stereoselective Ca2+-sensitizing effect but not to stereoselective phosphodiesterase inhibition. Kaheinen P; Pollesello P; Hertelendi Z; Borbély A; Szilágyi S; Nissinen E; Haikala H; Papp Z Basic Clin Pharmacol Toxicol; 2006 Jan; 98(1):74-8. PubMed ID: 16433895 [TBL] [Abstract][Full Text] [Related]
36. Cardiac effects of adenosine and adenosine analogs in guinea-pig atrial and ventricular preparations: evidence against a role of cyclic AMP and cyclic GMP. Brückner R; Fenner A; Meyer W; Nobis TM; Schmitz W; Scholz H J Pharmacol Exp Ther; 1985 Sep; 234(3):766-74. PubMed ID: 2993594 [TBL] [Abstract][Full Text] [Related]
37. Positive inotropic effect of 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1 -piperazinyl]-2(1H)-quinolinone (OPC-8212) and mechanism of action in guinea pig ventricular myocardium. Takeya K; Yajima M; Kobayashi-Ando S; Ando H Arzneimittelforschung; 1984; 34(3A):364-70. PubMed ID: 6331466 [TBL] [Abstract][Full Text] [Related]
38. Cardiac profile of EGIS-9377, a novel cardiotonic agent as a Ca2+ sensitizer with bradycardiac activity. Hattori Y; Ishitani T; Tomita F; Gando S; Yokoshiki H; Azuma M; Kemmotsu O; Kanno M Naunyn Schmiedebergs Arch Pharmacol; 1999 Nov; 360(5):585-90. PubMed ID: 10598798 [TBL] [Abstract][Full Text] [Related]
39. [The effect of the benzimidazole derivative AR-L 115 BS on the activities of myocardial adenylate cyclase and phosphodiesterase preparations (author's transl)]. Schuhmacher P; Greeff K; Noack E Arzneimittelforschung; 1982; 32(1):80-2. PubMed ID: 6277343 [TBL] [Abstract][Full Text] [Related]
40. Evidence for adenosine receptor-mediated isoprenaline-antagonistic effects of the adenosine analogs PIA and NECA on force of contraction in guinea-pig atrial and ventricular cardiac preparations. Böhm M; Brückner R; Meyer W; Nose M; Schmitz W; Scholz H; Starbatty J Naunyn Schmiedebergs Arch Pharmacol; 1985 Nov; 331(2-3):131-9. PubMed ID: 3003587 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]